Patterns of treatment in men with intermediate-, high-, and very high-risk prostate cancer according to their modelled life expectancy

被引：0
|
作者：
Irenaeus, S. [1 ]
Garmo, H. [2 ]
Gedeborg, R. [2 ]
Robinson, D. [3 ]
Stattin, P. [2 ]
Beckmann, K. [4 ]
机构：
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[2] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[3] Highland Hosp, Dept Urol, Eksjo, Sweden
[4] Univ South Australia, Canc Epidemiol & Populat Hlth Res Grp, Adelaide, SA, Australia
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0424
引用
收藏
页码：S1265 / S1266
页数：2
相关论文
共 50 条
  • [21] Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review
    Laukhtina, Ekaterina
    Sari Motlagh, Reza
    Mori, Keiichiro
    Quhal, Fahad
    Schuettfort, Victor M.
    Mostafaei, Hadi
    Katayama, Satoshi
    Grossmann, Nico C.
    Ploussard, Guillaume
    Karakiewicz, Pierre I.
    Briganti, Alberto
    Abufaraj, Mohammad
    Enikeev, Dmitry
    Pradere, Benjamin
    Shariat, Shahrokh F.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (11) : 4085 - 4099
  • [22] Outcomes for Patients With Intermediate-, High-, and Very-High-Risk Prostate Cancer Treated With a Combination of External Beam Radiation Therapy and Brachytherapy
    Kiffel, J.
    Kiffel, E. R.
    Mandel, A. L.
    Stone, N. N.
    Stock, R. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E199 - E200
  • [23] Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer
    Chan, June M.
    Oh, William K.
    Xie, Wanling
    Regan, Meredith M.
    Stampfer, Meir J.
    King, Irena B.
    Abe, Miyako
    Kantoff, Philip W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) : 3577 - 3583
  • [24] Contemporary treatment patterns and short-term outcomes in men with very high-risk prostate cancer.
    Tosoian, Jeffrey J.
    Sundi, Debasish
    Chapin, Brian Francis
    Antonarakis, Emmanuel S.
    Chappidi, Meera
    Alam, Ridwan
    Glavaris, Stephanie
    Karnes, R. Jeffrey
    Pienta, Kenneth J.
    Tran, Phuoc T.
    Schaeffer, Edward M.
    Ross, Ashley
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [25] Alternate definitions of adverse pathology to predict a very high risk of metastasis in men with intermediate- and low-risk prostate cancer
    Castaneda, Peris
    Kuhlmann, Paige K.
    Ithisuphalap, Jaruda
    Howard, Lauren E.
    Klaassen, Zachary
    Rivera, Lourdes Guerrios
    Amling, Christopher L.
    Aronson, William J.
    Cooperberg, Matthew R.
    Kane, Christopher J.
    Terris, Martha K.
    Freedland, Stephen J.
    CANCER, 2025, 131 (01)
  • [26] Overview of the current role of stereotactic body radiotherapy in the treatment of unfavorable intermediate- and high-risk prostate cancer
    Mezeckis, Maris
    Vesprini, Danny
    Buryk, Vladyslav
    Miszczyk, Leszek
    Vjaters, Egils
    JOURNAL OF RADIOSURGERY AND SBRT, 2022, 8 (02): : 95 - 103
  • [27] Geography and Insurance Status: Underestimated Factors Influencing Treatment Decisions in Intermediate- and High-Risk Prostate Cancer
    Beck, R.
    Green, W. R.
    Kim, S.
    Motwani, S. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E231 - E231
  • [28] The 17-gene Genomic Prostate Score® assay as a predictor of biochemical recurrence in men with intermediate- and high-risk prostate cancer
    Helfand, B. T.
    Paterakos, M.
    Wang, C-H.
    Talaty, P.
    Abran, J.
    Bennett, J. P.
    Hall, D. W.
    Aboushwareb, T.
    EUROPEAN UROLOGY, 2021, 79 : S1709 - S1710
  • [29] Outcomes of High-Dose Rate Brachytherapy for Intermediate- to High-Risk Prostate Cancer at One Institution
    Lin, E. Y.
    Lee, A.
    Demanes, J.
    Kamrava, M.
    Venkat, P. S.
    Hagio, M. A.
    Zaide, L. B.
    Park, S. J.
    Zarate, C.
    Chang, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E927 - E927
  • [30] Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer
    Bryant, Alex K.
    McKay, Rana R.
    Kader, A. Karim
    Parsons, J. Kellogg
    Einck, John P.
    Kane, Christopher J.
    Mundt, Arno J.
    Murphy, James D.
    Rose, Brent S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : 1068 - 1076
12345